#biotech-stocks
#biotech-stocks

[ follow ]

3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next

Investors must evaluate which biotech company has a viable plan for future growth amidst declining stock performances post-COVID-19 vaccine boom.

DeepSeek's poor performance leads to its removal from the market experiment.

Berkshire Hathaway resumed acquiring shares of Sirius XM, increasing its stake to over 124.8 million shares, representing about 37% of the company.

Venture

[ Load more ]